Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
BIOTRICITY INC. (BTCY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/04/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
8-K
| Quarterly results|
Docs:
|
"Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow",
"Biotricity Announces Reverse Stock Split REDWOOD CITY, CA / ACCESSWIRE / June 30, 2023 / Biotricity Holdings, Inc. , a medical diagnostic and consumer healthcare technology company, today it will effect a reverse stock split of its common stock. Biotricity expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on July 3, 2023." |
|
| 06/29/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
| 05/18/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"SUBSCRIPTION AGREEMENT",
"CONVERTIBLE PROMISSORY NOTE THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH, OR PURSUANT TO AN EXEMPTION FROM, THE REQUIREMENTS OF SUCH ACT OR SUCH LAWS. BIOTRICITY INC. CONVERTIBLE PROMISSORY NOTE",
"WARRANT THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED , OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. No. [__] Issue Date: [DATE] Biotricity Inc. Common Stock Purchase Warrant _________________ THIS CERTIFIES THAT, for value received, [_____] is entitled to subscribe for and purchas...",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)" |
|
| 04/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/22/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/02/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 02/14/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 01/27/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ... |
| 01/20/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 11/18/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/16/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/11/2022 |
8-K
| Quarterly results |
| 07/15/2022 |
8-K
| Quarterly results |
| 07/14/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 06/29/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 05/06/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/26/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/14/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 04/08/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 03/22/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/22/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 02/16/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/14/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
| 01/21/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"CREDIT AGREEMENT among BIOTRICITY INC., as Borrower, SWK FUNDING LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the financial institutions party hereto from time to time as Lenders Dated as of December 21, 2021",
"WARRANT THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED , OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. No. SWK – CS – 1 December 21, 2021 Biotricity Inc. Common Stock Purchase Warrant THIS CERTIFIES THAT, for value received, SWK FUNDING LLC, or its registered assigns , is entitled to...",
"GUARANTEE AND COLLATERAL AGREEMENT Guarantee and Collateral Agreement, dated as of December 21, 2021 , made by each signatory hereto , in favor of SWK Funding LLC, as administrative and collateral agent for the benefit of all Lenders party to the Credit Agreement . Agent and Lenders have severally agreed to extend credit to BIOTRICITY INC., a Nevada corporation , pursuant to the Credit Agreement . Borrower is affiliated with each other Grantor. Borrower and the other Grantors are engaged in interrelated businesses, and each Grantor will derive substantial direct and indirect benefit from extensions of credit under the Credit Agreement. It is a condition precedent to each Lender’ s obligation to extend credit under the Credit Agreement that Grantors shall have executed and delivered this Ag...",
"Schedule I" |
|
| 12/08/2021 |
8-K
| Quarterly results |
| 12/07/2021 |
8-K
| Quarterly results |
|
|
|